Marin Protein Hydrolysate and Metabolic Syndrome

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

February 15, 2019

Primary Completion Date

December 31, 2019

Study Completion Date

April 30, 2020

Conditions
Metabolic Syndrome
Interventions
DIETARY_SUPPLEMENT

MPH_active

One daily intake at breakfast of supplementary marine protein hydrolysate (MPH), a dosage of X mg, duration 8 weeks. The form is powder, flavored with lemon, and to be mixed with 100 ml water. Random sequence of arms.

DIETARY_SUPPLEMENT

MPH_placebo

One daily intake at breakfast of supplementary placebo, a dosage of X mg, duration 8 weeks. The form is powder, flavored with lemon, and to be mixed with 100 ml water.

Trial Locations (2)

Unknown

Ålesund Hospital, Helse Møre og Romsdal HF, Ålesund

Haukeland University Hospital, Bergen

All Listed Sponsors
collaborator

Haukeland University Hospital

OTHER

collaborator

University of Bergen

OTHER

lead

Helse Møre og Romsdal HF

OTHER_GOV

NCT03807752 - Marin Protein Hydrolysate and Metabolic Syndrome | Biotech Hunter | Biotech Hunter